Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.63 CHF | +4.81% | +4.46% | +51.52% |
Apr. 17 | Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member | CI |
Mar. 19 | Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+51.52% | 148M | |
-4.06% | 86.13B | |
+1.32% | 39.82B | |
+56.34% | 25.23B | |
-15.17% | 15.36B | |
-9.14% | 11.95B | |
-16.60% | 11.6B | |
-43.00% | 11.51B | |
+6.37% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- NWRN Stock
- News Newron Pharmaceuticals S.p.A.
- Newron Pharmaceuticals S.p.A. announced that it has received €40 million in funding from European Investment Bank, Investment Arm